Heterogeneous Response of Airway Eosinophilia to Anti-IL-5 Biologics in Severe Asthma Patients
Many questions concerning responders (R) and nonresponders (NR) in severe eosinophilic asthma (SEA) after blocking the IL-5 (interleukin 5) pathway are still not clear, especially regarding the early parameters of response to biologics in personalized treatment strategies. We evaluated 17 SEA patien...
Main Authors: | Maruša Kopač Šokić, Matija Rijavec, Peter Korošec, Urška Bidovec-Stojkovič, Izidor Kern, Romana Vantur, Sabina Škrgat |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/12/1/70 |
Similar Items
-
T2-high Asthma, Classified by Sputum mRNA Expression of <i>IL4</i>, <i>IL5</i>, and <i>IL13</i>, is Characterized by Eosinophilia and Severe Phenotype
by: Matija Rijavec, et al.
Published: (2021-01-01) -
Characteristics of Induced-Sputum Inflammatory Phenotypes in Adults with Asthma: Predictors of Bronchial Eosinophilia
by: Crespo-Lessmann A, et al.
Published: (2023-01-01) -
Characteristics of Induced-Sputum Inflammatory Phenotypes in Adults with Asthma: Predictors of Bronchial Eosinophilia [Corrigendum]
by: Crespo-Lessmann A, et al.
Published: (2023-11-01) -
Frequency of Raised Total Serum Ig E, Sputum Eosinophilia and Blood Eosinophil Count in Patients with Severe Persistent Asthma
by: Shanawer Qaiser, et al.
Published: (2021-01-01) -
Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD
by: Negewo NA, et al.
Published: (2016-07-01)